Alkermes Plc (ALKS)
28.63
+0.28
(+0.99%)
USD |
NASDAQ |
Mar 06, 16:00
28.64
0.00 (0.00%)
After-Hours: 20:00
Alkermes SG&A Expense (TTM) : 701.52M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Krystal Biotech, Inc. | 146.91M |
| Avadel Pharmaceuticals Plc | 191.46M |
| Assertio Holdings, Inc. | 63.52M |
| Amarin Corp. Plc | 106.17M |
| Amicus Therapeutics, Inc. | 383.49M |